EUVIMEDEUVIMED entdecken
Crossref

Correlation NKX2.2 IHC and EWSR1 break-apart FISH in the diagnosis of Ewing sarcoma

Sunil Pasricha, Saloni Pahwa, Manish Pruthi, Ankush Jajodia, Gurudutt Gupta, Anila Sharma, Garima Durga, Meenakshi Kamboj, Akshay Tiwari, Manoj Panigrahi, Anurag Mehta

Indian Journal of Pathology and Microbiology · 2023

DOI: 10.4103/ijpm.ijpm_535_21 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Pathology and Microbiology, 2023. Verfasst von Sunil Pasricha und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Rajiv Gandhi Cancer Institute and Research Centre, Saket, Delhi, India. Hauptthemen laut MEDLINE: Chondrosarcoma, Mesenchymal, Neuroblastoma, Neuroectodermal Tumors, Primitive, Peripheral, Sarcoma. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Ewing sarcoma (ES) are malignant small round cell tumors (MSRCT) characterized by rearrangements of EWSR1 gene. Although gold standard for diagnosis is detection of specific fusion genes by molecular testing, these ancillary tests are costly and only available in limited number of settings. There is a persuasive evidence for reliability of NKX2.2 immunohistochemistry (IHC) as a surrogate marker for EWSR1 gene rearrangement in ES.

Aims

The aim of this study is to correlate the NKX2.2 immuno-expression with genetically confirmed ES cases and also to assess the reliability and accuracy of NKX2.2 along with combined positivity of NXX2.2 and CD99 in diagnosing ES and differentiating it from other relevant histological mimics. Settings and Design: The present study is a retrospective study conducted over a period of 6-year duration in a tertiary cancer care center. Methods and Material: We evaluated NKX2.2 immunoexpression in 35 genetically confirmed cases of ES and also in pertaining differential entities ( n = 58) of ES including rhabdomyosarcoma ( n = 20), lymphoblastic lymphoma ( n = 14), Wilms tumor ( n = 10), poorly differentiated synovial sarcoma ( n = 4), small-cell osteosarcoma ( n = 4), neuroblastoma ( n = 5), and mesenchymal chondrosarcoma ( n = 1). CD99 was performed in the category of MSRCTs showing NKX2.2 positivity to evaluate combined specificity for the diagnosis of ES.

Results

Of the 35 genetically confirmed cases of ES, 29 cases (83%) showed NKX2.2-positive expression (83% sensitivity). Compared to ES, NKX2.2 was positive in only 05% cases (3/58 cases) of non-ES MSRCT. Only two of five cases of neuroblastomas and one case of mesenchymal chondrosarcoma showed NKX2.2 positivity. CD99 positivity was seen in 100% of ES and in the single case of mesenchymal chondrosarcoma. All five cases (100%) of neuroblastoma were negative for CD99.

Conclusions

The presented study, which is the first from an Indian oncology center, showed NKX2.2 IHC is quite reliable in diagnosis of ES in the right clinicopathological context. With remarkable sensitivity and specificity of NKX2.2 IHC for diagnosis of ES, we propose that combined positivity of CD99 and NKX2.2 IHC can obviate or minimize the need of EWSR1 gene rearrangement molecular testing for diagnosis of ES.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chondrosarcoma, MesenchymalNeuroblastomaNeuroectodermal Tumors, Primitive, PeripheralSarcomaSarcoma, EwingHumans12E7 AntigenBiomarkers, TumorImmunohistochemistryReproducibility of ResultsRetrospective StudiesRNA-Binding Protein EWSTranscription FactorsHomeobox Protein Nkx-2.2

Stichwörter der Autor:innen

CD99EWSR1 gene rearrangementEwing sarcomaNKX2.2immunohistochemistry

Substanzen

12E7 AntigenBiomarkers, TumorCD99 protein, humanEWSR1 protein, humanRNA-Binding Protein EWSTranscription FactorsHomeobox Protein Nkx-2.2

Autor:innen und Institutionen

  • Department of Pathology, Rajiv Gandhi Cancer Institute and Research Centre, Saket, Delhi, India.
  • Department of Musculoskeletal Oncology, Rajiv Gandhi Cancer Institute and Research Centre, Saket, Delhi, India.
  • Department of Radiology, Rajiv Gandhi Cancer Institute and Research Centre, Saket, Delhi, India.
  • Department of Orthopedics, Max SuperSpeciality Hospital, Saket, Delhi, India.
  • Department of Molecular Pathology, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India.

Zitieren

APA

Pasricha, S., Pahwa, S., Pruthi, M., Jajodia, A., Gupta, G., Sharma, A., Durga, G., Kamboj, M., Tiwari, A., Panigrahi, M., & Mehta, A. (2023). Correlation NKX2.2 IHC and EWSR1 break-apart FISH in the diagnosis of Ewing sarcoma. Indian Journal of Pathology and Microbiology. https://doi.org/10.4103/ijpm.ijpm_535_21

Vancouver

Pasricha S, Pahwa S, Pruthi M, Jajodia A, Gupta G, Sharma A, et al. Correlation NKX2.2 IHC and EWSR1 break-apart FISH in the diagnosis of Ewing sarcoma. Indian Journal of Pathology and Microbiology. 2023. doi:10.4103/ijpm.ijpm_535_21

BibTeX
@article{Pasricha2023,
  author = {Pasricha, Sunil and Pahwa, Saloni and Pruthi, Manish and Jajodia, Ankush and Gupta, Gurudutt and Sharma, Anila and Durga, Garima and Kamboj, Meenakshi and Tiwari, Akshay and Panigrahi, Manoj and Mehta, Anurag},
  title = {Correlation NKX2.2 IHC and EWSR1 break-apart FISH in the diagnosis of Ewing sarcoma},
  journal = {Indian Journal of Pathology and Microbiology},
  year = {2023},
  doi = {10.4103/ijpm.ijpm_535_21}
}
Kostenlos starten →